Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NGR-hTNF in Advanced Colorectal Cancer
NCT00483080Phase 2Completed
- Sponsor
- AGC Biologics
- Start
- Dec 2006
- Primary completion
- Jun 2009
- Modality
- Peptides, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of NGR-TNF in colorectal cancer (CRC), sponsored by AGC Biologics. Started Dec 2006; status: completed.
02
Drugs
NGR-TNF
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00483080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00483080.